Soohyeon Lee

ORCID: 0000-0001-9665-062X · 2 papers in corpus
2022
·doi:10.21203/rs.3.rs-1174780/v1

Abstract Purpose: Bone-modifying agents (BMAs) are key components in the management of cancer patients with bone metastasis. Despite their clinical benefits, the use of BMAs is associated with adverse dental events including medication-rel…

2019
·doi:10.1101/515486

Disease heterogeneity of immune gene expression patterns of luminal breast cancer (BC) has not been well studied. We performed immune gene expression profiling of tumor and adjacent normal tissue in 92 Asian luminal BC patients and identifi…